Agomab Therapeutics Selected as One of Fierce Biotech’s “Fierce 15” Companies of 2022
Agomab Therapeutics NV (‘Agomab’) today announced that Fierce Biotech has named the company as one of 2022’s Fierce 15 biotechnology companies, designating it as one of the most promising early-stage biotechnology companies in the industry.
Recent Comments